Journal of Vaccines & Vaccination

16^th Euro Global Summit and Expo on Vaccines & Vaccination

June 19-21, 2017 Paris, France

Posters & Accepted Abstracts

• Development of a peptide vaccine platform for brain tumor immunotherapy that incorporates adjuvant CD27 stimulation for enhanced T cell immunity

  Katherine Riccione

  PDF HTML

• Clostridium difficile flagellin FliC as an adjuvant to induce a protective gut mucosal immune response

  Jean-Francois Bruxelle, Assaf Mizrahi, Anne Collignon and Claire Janoir

  PDF HTML

• LPS/endotoxins molecular diversity impacting vaccines and adjuvants activities and toxicity

  Alexey Novikov and Martine Caroff

  PDF HTML

• Construction for minimal positive conditions for the safety of brain from vaccines to be supplied quickly at widespread epidemics

  Sun Shin Yi, Kwang Ho Kim, Min Young Park, Bokyeong Ko, Kyeong Ryun Kim and Do Eun Kim

  PDF HTML

• Development and preclinical evaluation of 15 pneumococcal polysaccharide CRM197 conjugate candidate vaccines in mouse model

  Huyen T Pham, Chanwoo Park, Kim Doh Hoon, Ju-Hwan Kim, Hyo-Jin Kang, Do-Young Yoon, Rock-Ki Kim, Sung-Kyun Lee, Yoon-Hee Whang, Chan-Kyu Lee and Suenie Park

  PDF HTML

• Study for establishment of 1st National Reference Standard for cell-derived Japanese encephalitis vaccine (Beijing strain)

  Ji Young Hong, Sangil Choi, Sunbo Shim and Sangja Ban

  PDF HTML

• Flavivirus nonstructural protein 1-based recombinant vaccines

  Ching-Len Liao

  PDF HTML

• Heterologous prime-boost tetravalent dengue vaccine strategy elicits complete protection against DENV-2 in non-human primates

  Chutitorn Ketloy, Eakachai Prompetchara, Poonsook Keelapang, Nopporn Sittisombut and Kiat Ruxrungtham

  PDF HTML

• Tumor liberated protein (TLP) as potential vaccine for lung cancer patients

  Giulio Tarro

  PDF HTML

• Universally protective vaccines: A revolution in modern vaccinology

  Geert Vanden Bossche

  PDF HTML

• Human vaccines project: Decoding the human immune system to accelerate next generation vaccine development

  Wayne C Koff

  PDF HTML

• Virus safety for viral vaccines and vectors

  Anissa Boumlic-Courtade

  PDF HTML

• HIV DNA remaining not detectable two years after Tat Oyi vaccination in HIV infected volunteers under cART

  Erwann Loret

  PDF HTML

• T-cell therapeutic vaccine for autoimmune components of viral infections

  Henri Atlan

  PDF HTML

• Neutrophil-associated disruption of the granulomatous response in BCG-vaccinated mice exposed to environmental mycobacteria

  Marcela Henao-Tamayo, Brendan Podell and Ian Orme

  PDF HTML

• Construction of a recombinant vaccinia virus expressing E gene of Japanese encephalitis virus and immunogenicity in pigs

  Hui-jun Lu

  PDF HTML

• Characterization of recombinant vaccine constructed by individually cloning of HIV1 C gag, env and polRT genes using Semliki Forest virus vector

  A H Bandivdekar

  PDF HTML

• Use of O-specific polysaccharides for preparation of immunogenic conjugates of Salmonella enterica serovars Typhi and Paratyphi A

  Abdul Haque and Muhammad Aamir

  PDF HTML